2 not yet recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 2 |
Follow RCT: new trials by email Literature Review of RCT trials Research Report on RCT
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Controlled Trial Allogeneic Human Induced Pluripotent Stem Cell (iPSC)-Derived Motor Neuron Progenitor Cells, Placebo - Spinal Cord Injury, Safety | Phase 2 | Not yet recruiting | XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. | 60 | 2028-05-25 | 2025-11-25 |
| Perioperative Ivonescimab Plus S-1 and Oxaliplatin (SOX) for Locally Advanced Gastric or GEJ Adenocarcinoma Ivonescimab (20mg/kg Q3W), Oxaliplatin, S-1 - Gastric Cancer, RCT | Phase 2 | Not yet recruiting | Sichuan University | 154 | 2026-02-01 | 2026-01-28 |
Spinal Cord Injuries (1) · Stomach Neoplasms (1)
Central Nervous System Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Nervous System Diseases (1) · Spinal Cord Diseases (1) · Stomach Diseases (1) · Trauma, Nervous System (1) · Wounds and Injuries (1)
Oxaliplatin (1) · S 1 (combination) (1)
Sichuan University (1) · XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. (1)
China (2)
Gou Hongfeng (1) · Limin Rong, prof and M.D (1)
PMID 24737677, PMID 31513484, PMID 32606208, PMID 33538338, PMID 33792646, PMID 33852952, PMID 34796431, PMID 35969830, PMID 36603169, PMID 37963317